BioNexus Gene Lab Corp. Finance Lease, Right-of-Use Asset, Amortization
BioNexus Gene Lab Corp. (BGLC) reported Finance Lease, Right-of-Use Asset, Amortization of $2.72 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-14
- BioNexus Gene Lab Corp. finance lease, right-of-use asset, amortization for the quarter ending 2025-06-30 was -$13.38K, a 218.90% decline year-over-year.
- BioNexus Gene Lab Corp. finance lease, right-of-use asset, amortization for the quarter ending 2025-03-31 was $13.38K, a 41.61% increase year-over-year.
- BioNexus Gene Lab Corp. finance lease, right-of-use asset, amortization for the quarter ending 2024-12-31 was $13.48K, a 41.11% increase year-over-year.
- BioNexus Gene Lab Corp. finance lease, right-of-use asset, amortization for the quarter ending 2024-09-30 was $14.81K, a 91.58% increase year-over-year.
- BioNexus Gene Lab Corp. finance lease, right-of-use asset, amortization for fiscal 2024 was $48.98K, a 94.61% increase from fiscal 2023.
- BioNexus Gene Lab Corp. finance lease, right-of-use asset, amortization for fiscal 2023 was $25.17K, a 79.89% increase from fiscal 2022.
- BioNexus Gene Lab Corp. finance lease, right-of-use asset, amortization for fiscal 2022 was $13.99K, a 17.37% decline from fiscal 2021.
- BioNexus Gene Lab Corp. finance lease, right-of-use asset, amortization for fiscal 2021 was $16.93K, a 56.56% increase from fiscal 2020.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.72K 10-Q · filed 2026-08-14 | |||
| 2025-06-30 | -$13.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $13.48K derived: sum of 3 quarters · filed 2026-08-14 | $28.28K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $13.38K 10-Q · filed 2025-05-15 | $26.86K derived: sum of 2 quarters · filed 2025-05-15 | $41.66K derived: sum of 3 quarters · filed 2025-05-15 | $52.91K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $13.48K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $28.28K derived: sum of 2 quarters · filed 2025-04-15 | $39.53K derived: sum of 3 quarters · filed 2025-04-15 | $48.98K 10-K · filed 2025-04-15 |
| 2024-09-30 | $14.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | $26.06K derived: sum of 2 quarters · filed 2024-11-15 | $35.51K 10-Q · filed 2024-11-15 | $45.06K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | $11.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $20.70K 10-Q · filed 2024-08-14 | $30.25K derived: sum of 3 quarters · filed 2025-05-15 | $37.98K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $9.45K 10-Q · filed 2025-05-15 | $19.00K derived: sum of 2 quarters · filed 2025-05-15 | $26.73K derived: sum of 3 quarters · filed 2025-05-15 | $30.65K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $9.55K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $17.28K derived: sum of 2 quarters · filed 2025-04-15 | $21.20K derived: sum of 3 quarters · filed 2025-04-15 | $25.17K 10-K · filed 2025-04-15 |
| 2023-09-30 | $7.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | $11.65K derived: sum of 2 quarters · filed 2024-11-15 | $15.62K 10-Q · filed 2024-11-15 | $16.86K derived: sum of 4 quarters · filed 2024-11-15 |
| 2023-06-30 | $3.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $7.89K 10-Q · filed 2024-08-14 | $9.13K derived: sum of 3 quarters · filed 2024-08-14 | $13.30K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $3.97K 10-Q · filed 2024-05-15 | $5.21K derived: sum of 2 quarters · filed 2024-05-15 | $9.38K derived: sum of 3 quarters · filed 2024-05-15 | $13.62K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $1.24K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $5.41K derived: sum of 2 quarters · filed 2024-04-16 | $9.65K derived: sum of 3 quarters · filed 2024-04-16 | $13.99K 10-K · filed 2024-04-16 |
| 2022-09-30 | $4.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $8.41K derived: sum of 2 quarters · filed 2022-11-14 | $12.75K 10-Q · filed 2022-11-14 | $16.48K derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-06-30 | $4.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $8.59K 10-Q · filed 2022-08-15 | $12.31K derived: sum of 3 quarters · filed 2023-03-31 | $16.66K derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-03-31 | $4.34K 10-Q · filed 2022-05-16 | $8.06K derived: sum of 2 quarters · filed 2023-03-31 | $12.41K derived: sum of 3 quarters · filed 2023-03-31 | $16.84K derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-12-31 | $3.72K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $8.07K derived: sum of 2 quarters · filed 2023-03-31 | $12.50K derived: sum of 3 quarters · filed 2023-03-31 | $16.93K 10-K · filed 2023-03-31 |
| 2021-09-30 | $4.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $8.78K derived: sum of 2 quarters · filed 2022-11-14 | $13.21K 10-Q · filed 2022-11-14 | $15.82K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $4.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $8.86K 10-Q · filed 2022-08-15 | $11.47K derived: sum of 3 quarters · filed 2022-08-15 | $14.51K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $4.43K 10-Q · filed 2022-05-16 | $7.04K derived: sum of 2 quarters · filed 2022-05-16 | $10.08K derived: sum of 3 quarters · filed 2022-05-16 | $12.38K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $2.61K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $5.64K derived: sum of 2 quarters · filed 2022-04-06 | $7.95K derived: sum of 3 quarters · filed 2022-04-06 | $10.82K 10-K · filed 2022-04-06 |
| 2020-09-30 | $3.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $8.21K 10-Q · filed 2020-11-03 | $8.21K 10-Q · filed 2021-11-15 | $19.83K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $2.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $5.17K 10-Q · filed 2021-08-12 | $16.79K derived: sum of 3 quarters · filed 2021-08-12 | $16.79K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $2.87K 10-Q · filed 2021-05-18 | $14.48K derived: sum of 2 quarters · filed 2021-05-18 | $14.48K derived: sum of 3 quarters · filed 2021-05-18 | |
| 2019-12-31 | $11.62K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-30 | $11.62K derived: sum of 2 quarters · filed 2021-03-30 | $11.62K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 10-Q/A · filed 2020-11-09 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |